MedTrace Logo

PREVENT Pilot HPV - Related Cancers Trial

NCT06738355 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 335

Last updated 2026-03-20

No results posted yet for this study

Summary

This study will serve as one of the first to develop and test the effectiveness of strategies to promote HPV vaccination among diverse rural parents and caregivers of children ages 9-17 years in the Mountain West. Once implemented into practice, our intervention could significantly reduce disparities in the burden of HPV-associated cancers among rural populations in the United States.

The proposed study will assess the feasibility of clinic-based outreach to increase vaccination rates for HPV at four community clinics in rural counties in Washington.

Conditions

  • HPV Vaccination
  • Uptake Vaccination
  • Series Completion

Interventions

BEHAVIORAL

PREVENT

The proposed study will assess the feasibility of an RCT for clinic-based outreach to increase vaccination rates for HPV at community clinics in rural counties. The study is a pilot trial that will assign adult parent/caregiver participants to a timeline for receiving the vaccination messaging intervention. Auto and Auto-Plus intervention arms may use some of the same components (automated calls, live calls, text messages, emails, and mailings).

Sponsors & Collaborators

  • Kaiser Permanente

    collaborator OTHER

  • University of Arizona

    collaborator OTHER

  • Sea Mar Community Health Centers

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • University of Utah

    lead OTHER

Principal Investigators

  • Deanna Kepka, PhD, MPH · Study Principal Investigator

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-05-20
Primary Completion
2025-08-12
Completion
2025-08-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06738355 on ClinicalTrials.gov